ARIAD PHARMACEUTICALS $17.79

down -0.03


18/6/2013 04:18 PM  |  NASDAQ : ARIA  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get ARIA Trend Analysis - it has underperformed the S&P 500 by 22%

ETF Alternatives



People viewing ARIA also viewed: , , , ,

Competitors

Ticker Name Volume % Change
RXEI RXELITE 45.2K +4.00%
ALSE ALSERES PHARMACEUTICALS 600.0 +1.00%
ALLP ALLIANCE PHARMACEUTICAL 3.5K +0.82%
KVPBQ K-V PHARMACEUTICAL 1.4K +0.82%
HRDN DC BRANDS INTERNATIONAL INC. C 16.7M +0.67%
View All

ARIA Stock Analysis

  1.

    Ariad's Iclusig in GIST Phase II Study - Analyst Blog

    (PFE,NVS,ARIA,JAZZ )
    The study will evaluate Iclusig's efficacy and safety in patients who have failed at least one tyrosine kinase inhibitor therapy.
Free Reports
  1.

    5 Chart Patterns Every Investor Needs To Know

    Learn How to Use Technical Analysis to Your Advantage.
  2.

    Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  3.

    Get 10 Trading Lessons FREE

    Benefit from the knowledge of MarketClub co-founder Adam Hewison and our other trading experts, with this FREE series of educational emails and online content.
Marketplace
Trading Center